CRYOPORT INC (CYRX)
US2290503075 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to CYRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.7. This target is 15.22% above the current price.
CYRX was analyzed by 16 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CYRX.
In the previous month the buy percentage consensus was at a similar level.
CYRX was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | UBS | Maintains | Neutral -> Neutral |
| 2024-03-13 | Needham | Maintains | Buy -> Buy |
| 2024-03-13 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-01-18 | Needham | Maintains | Buy -> Buy |
| 2023-08-17 | Morgan Stanley | Initiate | Equal-Weight |
| 2023-08-10 | Needham | Maintains | Buy -> Buy |
| 2023-07-18 | UBS | Downgrade | Buy -> Neutral |
| 2023-07-17 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-07-17 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2023-07-13 | Roth MKM | Maintains | Buy -> Buy |
| 2023-07-13 | Needham | Reiterate | Buy -> Buy |
| 2023-07-13 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-07-13 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2023-07-13 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-06-06 | UBS | Maintains | Buy -> Buy |
| 2023-05-05 | Needham | Reiterate | Buy |
| 2023-04-21 | Needham | Reiterate | Buy |
| 2023-02-24 | Needham | Maintains | Buy |
| 2022-12-08 | Keybanc | Maintains | Overweight |
| 2022-11-16 | B. Riley Securities | Maintains | Buy |
| 2022-11-04 | Needham | Maintains | Buy |
| 2022-11-04 | Keybanc | Maintains | Overweight |
| 2022-11-04 | SVB Leerink | Maintains | Outperform |
| 2022-07-12 | Needham | Maintains | Buy |
| 2022-05-06 | Needham | Maintains | Buy |
| 2022-05-06 | Keybanc | Maintains | Overweight |
| 2022-05-02 | SVB Leerink | Maintains | Outperform |
| 2022-02-25 | Needham | Maintains | Buy |
| 2022-02-25 | SVB Leerink | Maintains | Outperform |
| 2022-01-19 | Roth Capital | Upgrade | Neutral -> Buy |